New Delhi: India’s drug regulator has allowed The AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, News18 quoted Reuters as saying.
The approval, given to a licensed version of the drug made by the Serum Institute of India (SII) and exported to dozens of countries, could help health authorities to minimise vaccine wastage and better plan their inoculation programmes.
Some African countries have only until the middle of next month to use up more than a million doses of the vaccine branded Covishield by SII if the shelf life is not extended.
“You are permitted to apply the shelf-life of 9 months to unlabelled vials available on hand,” India’s drug controller-general, V.G. Somani, wrote late last month in reply to a request from the SII.
Bhubaneswar: Odisha FC reigned supreme at Fortress Kalinga Stadium once more. Coming from behind in…
Bhubaneswar: The Odisha government on Friday quashed reports about closure of schools till June 15…
New Delhi: It was after weeks of drama and suspense that the people of Odisha…
Bhubaneswar: Odisha government has suspended Excise Superintendent of Kendrapada district Debi Prasad Mishra for dereliction…
Bengaluru: Actress Harshika Poonacha has alleged that she and her husband were harassed and attacked…
Bhubaneswar: BJP leader of Kendrapada Bijayketan Swain along with his supporters joined BJD on Friday.…
New Delhi: The first phase of voting for the 18th Lok Sabha elections was by…
Bhubaneswar: Odisha unit of BJP on Friday accused the BJD of misleading the voters of…